Hmm looking at the following table from a different website there were some AE's..though the commentary here suggests that overall it has a "favorable" safety profile? Wern't there like 4 deaths out of a sample of 2000 and a heap of Serious TEAE's?????
Maybe I'm not reading it right, here is the link:
https://acrabstracts.org/abstract/rheumatoid-arthritis-treatment-with-filgotinib-week-132-safety-data-from-a-phase-2b-open-label-extension-study/
I would like to see PPS's comparative table, I don't think we have had any AE's. Maybe a few upset stomachs and the odd headache and a little bruising around the injection site, cosmetic effects at best?
If Filgtiib has a favorable profile surely ours is 'very favorable' or even 'out of this world favorable' (sorry, I'm being flippant)
Here is the table I'm referring to for Filgotinib.Conclusion:
Filgotinib continues to demonstrate a favorable safety and tolerability profile in pts with RA over a 2.5-year period, with maintenance of therapeutic response in the long-term.
Table 1: Key Safety Events Per 100 PYE
Filgotinib (200mg daily) + MTX
Filgotinib (200mg daily) Monotherapy
Total*
PYE=1443
PYE=599
PYE=2042
Treatment-emergent AEs (TEAEs)
144.1
151.5
146.3
Serious TEAEs
5.1
6.8
5.6
TEAEs for Infections
41.6
36
40
Serious TEAEs for Infections
0.8
1.7
1
Malignancy (excluding NMSC†)
0.6
0.7
0.6
Herpes Zoster
1.5
1.5
1.5
Deep Vein Thrombosis‡
0.07
0
0.05
Pulmonary Embolism‡
0.07
0
0.05
Active Tuberculosis
0
0
0
Deaths
0.1
0.5
0.2
*Treatment groups with fewer than 10 subjects were omitted for clarity;†Non-melanoma skin cancer;
‡Single patient DVT leading to PE.
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-122
-
- There are more pages in this discussion • 4,065 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
31.0¢ |
Change
0.035(12.7%) |
Mkt cap ! $108.4M |
Open | High | Low | Value | Volume |
27.5¢ | 31.0¢ | 27.5¢ | $108.9K | 371.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 17420 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 0.300 |
2 | 54067 | 0.295 |
2 | 6448 | 0.290 |
3 | 70208 | 0.285 |
2 | 100000 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 17420 | 5 |
0.315 | 112073 | 3 |
0.320 | 120163 | 4 |
0.325 | 3050 | 2 |
0.330 | 29123 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |